QCOM Stock Analysis: Qualcomm | NASDAQ
Semiconductors | NASDAQ, USA | Market Cap: 167.384m USD | 12M Return: 2.4% | US7475251036 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.17B
EPS Trend: 43.0%
Qual. Beats: 0
Rev. Trend: 90.5%
Qual. Beats: 2
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
QUALCOMM Incorporated (NASDAQ: QCOM) is a U.S.-based technology company headquartered in San Diego, California, founded in 1985. It develops and commercializes foundational technologies for the wireless industry, operating through three segments: Qualcomm CDMA Technologies (QCT), which designs integrated circuits and system software for mobile devices, automotive systems, and IoT products; Qualcomm Technology Licensing (QTL), which licenses its patent portfolio covering cellular standards such as 3G, 4G, and 5G; and Qualcomm Strategic Initiatives (QSI), which invests in early-stage companies across areas including 5G, AI, automotive, IoT, and extended reality. The company also serves U.S. government agencies and provides software-based network security solutions.
QUALCOMM operates within the Information Technology sector, specifically the Semiconductors sub-industry, following a fabless business model in which it designs chips but relies on third-party foundries for manufacturing. Its dual revenue model combines chipset sales (QCT) with patent licensing (QTL), a structure that distinguishes it from many peers in the semiconductor space. The company trades as a mega-cap stock on NASDAQ and has been listed since its 1991 IPO.
- Handset chip ASPs pressured by Apple in-house modem transition
- Automotive and IoT revenue growth diversifies beyond smartphones
- China licensing revenue faces renewed regulatory and antitrust scrutiny
| Net Income: 13.6b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA -11.35 > 1.0 |
| NWC/Revenue: 23.87% < 20% (prev 37.51%; Δ -13.63% < -1%) |
| CFO/TA 0.18 > 3% & CFO 11.1b > Net Income 13.6b |
| Net Debt (8.31b) to EBITDA (11.7b): 0.71 < 3 |
| Current Ratio: 1.86 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.07b) vs 12m ago -2.90% < -2% |
| Gross Margin: 53.10% > 18% (prev 55.43%; Δ -2.33% > 0.5%) |
| Asset Turnover: 77.71% > 50% (prev 88.32%; Δ -10.60% > 0%) |
| Interest Coverage Ratio: 14.68 > 6 (EBIT TTM 10.1b / Interest Expense TTM 688.0m) |
| A: 0.17 (Total Current Assets 22.3b - Total Current Liabilities 12.0b) / Total Assets 60.8b |
| B: 0.45 (Retained Earnings 27.5b / Total Assets 60.8b) |
| C: 0.18 (EBIT TTM 10.1b / Avg Total Assets 55.5b) |
| D: 1.00 (Book Value of Equity 30.4b / Total Liabilities 30.4b) |
| Altman-Z'' = 4.86 = AA |
| DSRI: 1.00 (Receivables 4.20b/4.32b, Revenue 43.1b/44.3b) |
| GMI: 1.04 (GM 55.43% / 53.10%) |
| AQI: 1.33 (AQ_t 0.52 / AQ_t-1 0.39) |
| SGI: 0.97 (Revenue 43.1b / 44.3b) |
| TATA: 0.04 (NI 13.6b - CFO 11.1b) / TA 60.8b) |
| Beneish M = -2.81 (Cap -4..+1) = A |
As of November 13, 2026, the stock is trading at USD 177.14 with a total of 8,963,500 shares traded. Over the past week, the price has changed by +13.01%, over one month by +1.55%, over three months by +9.22% and over the past year by +2.35%.
Current recommended Stop Loss: 161.90 (which is 8.6% or 1.7 ATR below the current price).
Qualcomm has received a consensus analysts rating of 3.43. Therefore, it is recommended to hold QCOM.
- StrongBuy: 9
- Buy: 2
- Hold: 23
- Sell: 2
- StrongSell: 1
| Analysts Target Price | 197 | 11.2% |
P/E Trailing = 12.3425
P/E Forward = 17.452
P/S = 3.7982
P/B = 6.6866
P/EG = 0.7829
Revenue TTM = 43.1b USD
EBIT TTM = 10.1b USD
EBITDA TTM = 11.7b USD
Long Term Debt = 12.6b USD (from longTermDebt, last quarter)
Short Term Debt = 2.61b USD (from shortTermDebt, last quarter)
Debt = 16.0b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.31b USD (calculated: Debt 16.0b - CCE 7.68b)
Enterprise Value = 176b USD (167b + Debt 16.0b - CCE 7.68b)
Interest Coverage Ratio = 14.68 (Ebit TTM 10.1b / Interest Expense TTM 688.0m)
EV/FCF = 20.31x (Enterprise Value 176b / FCF TTM 8.65b)
FCF Yield = 4.92% (FCF TTM 8.65b / Enterprise Value 176b)
FCF Margin = 20.06% (FCF TTM 8.65b / Revenue TTM 43.1b)
Net Margin = 31.60% (Net Income TTM 13.6b / Revenue TTM 43.1b)
Gross Margin = 53.10% ((Revenue TTM 43.1b - Cost of Revenue TTM 20.2b) / Revenue TTM)
Gross Margin QoQ = 50.75% (prev 53.05%)
Tobins Q-Ratio = 2.89 (Enterprise Value 176b / Total Assets 60.8b)
Interest Expense / Debt = 4.30% (Interest Expense 688.0m / Debt 16.0b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 7.98b (EBIT 10.1b * (1 - 21.00%))
Current Ratio = 1.86 (Total Current Assets 22.3b / Total Current Liabilities 12.0b)
Debt / Equity = 0.53 (Debt 16.0b / totalStockholderEquity, last quarter 30.4b)
Debt / EBITDA = 0.71 (Net Debt 8.31b / EBITDA 11.7b)
Debt / FCF = 0.96 (Net Debt 8.31b / FCF TTM 8.65b)
Total Stockholder Equity = 27.1b (last 4 quarters mean from totalStockholderEquity)
RoA = 24.56% (Net Income 13.6b / Total Assets 60.8b)
RoE = 50.28% (Net Income TTM 13.6b / Total Stockholder Equity 27.1b)
RoCE = 25.43% (EBIT 10.1b / Capital Employed (Equity 27.1b + L.T.Debt 12.6b))
RoIC = 16.19% (NOPAT 7.98b / Invested Capital 49.3b)
WACC = 10.98% (E(167b)/V(183b) * Re(11.70%) + D(16.0b)/V(183b) * Rd(4.30%) * (1-Tc(0.21)))
Discount Rate = 11.70% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.78 | Cagr: -2.43%
[DCF] Terminal Value 63.97% ; FCFF base≈10.3b ; Y1≈9.05b ; Y5≈7.31b
[DCF] Fair Price = 69.11 (EV 82.1b - Net Debt 8.31b = Equity 73.8b / Shares 1.07b; r=10.98% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 42.97 | EPS CAGR: 5.31% | SUE: -0.07 | # QB: 0
Revenue Correlation: 90.51 | Revenue CAGR: 8.48% | SUE: 0.85 | # QB: 2
EPS current Quarter (2026-12-31): EPS=2.29 | Chg30d=-0.18% | Revisions=-17% | Analysts=25
EPS next Quarter (2027-03-31): EPS=2.32 | Chg30d=-0.44% | Revisions=-17% | Analysts=24
EPS current Year (2027-09-30): EPS=10.16 | Chg30d=-0.43% | Revisions=-17% | GrowthEPS=-3.6% | GrowthRev=+3.6%
EPS next Year (2028-09-30): EPS=12.85 | Chg30d=-0.81% | Revisions=-40% | GrowthEPS=+26.5% | GrowthRev=+15.7%
[Analyst] Revisions Ratio: -36% (up=3, down=8)